Key statistics
On Friday, Applied Therapeutics Inc (2UV:FRA) closed at 8.68, -8.10% below its 52-week high of 9.45, set on Nov 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.69 |
---|---|
High | 8.71 |
Low | 8.68 |
Bid | 9.08 |
Offer | 9.43 |
Previous close | 8.68 |
Average volume | 593.78 |
---|---|
Shares outstanding | 116.36m |
Free float | 110.26m |
P/E (TTM) | -- |
Market cap | 1.08bn USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 14:29 GMT.
More ▼
Announcements
- Applied Therapeutics Reports Third Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
- Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
- Applied Therapeutics to Participate in Upcoming Investor Conferences
- Applied Therapeutics Reports Second Quarter 2024 Financial Results
- Applied Therapeutics Added to Russell 3000® Index
- Applied Therapeutics Reports First Quarter 2024 Financial Results
- Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference
- Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer
- Applied Therapeutics to Present Results from Phase 3 ARISE-HF Study in Diabetic Cardiomyopathy at ACC 2024
More ▼